デフォルト表紙
市場調査レポート
商品コード
1747271

細胞シグナル伝達市場、製品タイプ別、シグナル伝達タイプ別、シグナル伝達経路別、技術別、用途別、エンドユーザー別、地域別

Cell Signaling Market, By Product, By Signaling Type, By Signaling Pathway, By Technology By Application, By End User, By Region


出版日
ページ情報
英文 140 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.36円
細胞シグナル伝達市場、製品タイプ別、シグナル伝達タイプ別、シグナル伝達経路別、技術別、用途別、エンドユーザー別、地域別
出版日: 2025年05月20日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の細胞シグナル伝達市場は、2025年に60億8,000万米ドルと推定され、2032年には101億5,000万米ドルに達すると予測され、2025年から2032年までのCAGRは7.6%で成長すると予測されます。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 60億8,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 7.60% 2032年の価値予測 101億5,000万米ドル

世界の細胞シグナル伝達市場は、バイオテクノロジーと医学研究の分野で重要な役割を果たす、急速に発展している分野です。シグナル伝達としても知られる細胞シグナル伝達は、細胞の成長、分化、代謝、アポトーシスなど様々な細胞活動を支配する複雑なコミュニケーションプロセスを指します。この複雑なシグナル伝達経路のネットワークは、細胞表面から核へのシグナル伝達を含み、特定の細胞応答を引き起こします。細胞シグナル伝達市場は、これらのシグナル伝達経路を研究・操作するために使用される試薬、アッセイキット、機器、ソフトウェアなど、幅広い製品と技術を包含しています。慢性疾患の増加や個別化医療に対する需要の高まりにより、細胞シグナル伝達市場は今後数年間で大きく成長する見込みです。

市場力学:

世界の細胞シグナル伝達市場は、細胞シグナル伝達経路の異常と関連するがん、糖尿病、心血管障害などの慢性疾患の罹患率の上昇など、いくつかの要因によって牽引されています。標的治療や個別化医療に対する需要の高まりは、この市場の成長をさらに促進しています。細胞シグナル伝達研究は、新規創薬標的の同定や標的治療薬の開発に重要な役割を果たしているからです。さらに、細胞生物学分野における研究開発活動への注目の高まりは、政府や民間団体からの資金提供の増加と相まって、市場の成長を促進すると予想されます。しかし、細胞シグナル製品および技術のコストが高いことに加え、熟練した専門家の不足が市場の成長をある程度妨げる可能性があります。さらに、創薬・開発プロセスに対する厳しい規制要件が、市場関係者に課題を突きつける可能性もあります。このような市場抑制要因にもかかわらず、細胞シグナル伝達市場は、特に医療費の増加と先進医療技術に対する意識の高まりが市場拡大の原動力になると予想される新興国において、大きな成長機会をもたらしています。

本調査の主な特徴

  • 本レポートでは、世界の細胞シグナル伝達市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模(10億米ドル)と年間平均成長率(CAGR%)を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の細胞シグナル伝達市場の主要企業をプロファイルしています。
  • このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
  • この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は、世界の細胞シグナル伝達市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の細胞シグナル伝達市場、製品別、2020年~2032年

  • 消耗品
  • 機器

第5章 世界の細胞シグナル伝達市場、シグナル伝達タイプ別、2020年~2032年

  • 分泌内リガンド
  • オートクリンリガンド
  • ジャクスタクリンリガンド
  • パラクリンリガンド
  • 内分泌リガンド

第6章 世界の細胞シグナル伝達市場、シグナル伝達経路別、2020年~2032年

  • MAPK/ERK経路
  • PI3K/Akt経路
  • Wnt経路
  • Notchシグナル伝達経路
  • NF-κB経路
  • JAK/STAT経路
  • TGF-B経路
  • カルシウムシグナル伝達経路

第7章 世界の細胞シグナル伝達市場、技術別、2020年~2032年

  • 顕微鏡検査
  • フローサイトメトリー
  • ウェスタンブロッティング
  • ELISA
  • 質量分析
  • 免疫組織化学
  • その他

第8章 世界の細胞シグナル伝達市場、用途別、2020年~2032年

  • がん調査
  • 免疫学
  • 神経科学
  • 心臓血管調査
  • 幹細胞調査、
  • その他(代謝異常など)

第9章 世界の細胞シグナル伝達市場、エンドユーザー別、2020年~2032年

  • 製薬およびバイオテクノロジー企業
  • 学術研究機関
  • 病院および臨床検査室
  • 政府機関
  • 受託研究機関

第10章 世界の細胞シグナル伝達市場、地域別、2020年~2032年

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋地域
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第11章 競合情勢

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • GE Healthcare
  • Roche Diagnostics
  • Sigma-Aldrich(part of Merck Group)
  • Abcam
  • PerkinElmer
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Promega Corporation
  • Cell Signaling Technology
  • QIAGEN
  • MilliporeSigma
  • Takara Bio

第12章 アナリストの推奨事項

  • 機会
  • アナリストの見解
  • Coherent Opportunity Map

第13章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7952

Global Cell Signaling Market is estimated to be valued at USD 6.08 Bn in 2025 and is expected to reach USD 10.15 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.08 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.60% 2032 Value Projection: USD 10.15 Bn

The global cell signaling market is a rapidly evolving sector that plays a crucial role in the field of biotechnology and medical research. Cell signaling, also known as signal transduction, refers to the complex communication process that governs various cellular activities, such as cell growth, differentiation, metabolism, and apoptosis. This intricate network of signaling pathways involves the transmission of signals from the cell surface to the nucleus, triggering specific cellular responses. The cell signaling market encompasses a wide range of products and technologies, including reagents, assay kits, instruments, and software, which are used to study and manipulate these signaling pathways. With the increasing prevalence of chronic diseases and the growing demand for personalized medicine, the cell signaling market is poised for significant growth in the coming years.

Market Dynamics:

The global cell signaling market is driven by several factors, including the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which are associated with aberrant cell signaling pathways. The increasing demand for targeted therapies and personalized medicine has further fueled the growth of this market, as cell signaling research plays a vital role in identifying novel drug targets and developing targeted therapeutics. Moreover, the growing focus on research and development activities in the field of cell biology, coupled with the increasing funding from government and private organizations, is expected to propel the market growth. However, the high cost of cell signaling products and technologies, along with the lack of skilled professionals, may hinder the market growth to some extent. Additionally, the stringent regulatory requirements for drug discovery and development processes may pose challenges to market players. Despite these restraints, the cell signaling market presents significant opportunities for growth, particularly in emerging economies, where the increasing healthcare expenditure and growing awareness about advanced medical technologies are expected to drive the market expansion.

Key Features of the Study:

  • This report provides in-depth analysis of the global cell signaling market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell signaling market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Roche Diagnostics, Sigma-Aldrich (part of Merck Group), Abcam, PerkinElmer, Becton, Dickinson and Company, Agilent Technologies, Promega Corporation, Cell Signaling Technology, QIAGEN, MilliporeSigma, and Takara Bio
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cell signaling market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell signaling market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2020 - 2032)
    • Consumables
    • Instruments
  • Signaling Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Intracrine ligands
    • Autocrine ligands
    • Juxtacrine ligand
    • Paracrine ligands
    • Endocrine ligands
  • Signaling Pathway Insights (Revenue, USD Bn, 2020 - 2032)
    • MAPK/ERK Pathway
    • PI3K/Akt Pathway
    • Wnt Pathway
    • Notch Signaling Pathway
    • NF-kB Pathway
    • JAK/STAT Pathway
    • TGF-B Pathway
    • Calcium Signaling Pathway
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Microscopy
    • Flow Cytometry
    • Western Blotting
    • ELISA
    • Mass Spectrometry
    • Immunohistochemistry
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cancer Research
    • Immunology
    • Neuroscience
    • Cardiovascular Research
    • Stem Cell Research,
    • Others (Metabolic disorders, etc.)
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical and Biotechnology Companies
    • Academic Research Institutions
    • Hospitals and Clinical Laboratories
    • Government Agencies
    • Contract Research Organizations
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific
    • Merck KGaA
    • Bio-Rad Laboratories
    • GE Healthcare
    • Roche Diagnostics
    • Sigma-Aldrich (part of Merck Group)
    • Abcam
    • PerkinElmer
    • Becton, Dickinson and Company
    • Agilent Technologies
    • Promega Corporation
    • Cell Signaling Technology
    • QIAGEN
    • MilliporeSigma
    • Takara Bio

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cell Signaling Market, By Product
    • Global Cell Signaling Market, By Signaling Type
    • Global Cell Signaling Market, By Signaling Pathway
    • Global Cell Signaling Market, By Technology
    • Global Cell Signaling Market, By Application
    • Global Cell Signaling Market, By End User
    • Global Cell Signaling Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Cell Signaling Market, By Product, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Cell Signaling Market, By Signaling Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Intracrine ligands
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autocrine ligands
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Juxtacrine ligand
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Paracrine ligands
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Endocrine ligands
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cell Signaling Market, By Signaling Pathway, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • MAPK/ERK Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • PI3K/Akt Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wnt Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Notch Signaling Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NF-kB Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • JAK/STAT Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • TGF-B Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Calcium Signaling Pathway
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Signaling Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Western Blotting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunohistochemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Signaling Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neuroscience
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Stem Cell Research,
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Metabolic disorders, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cell Signaling Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals and Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Cell Signaling Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sigma-Aldrich (part of Merck Group)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abcam
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cell Signaling Technology
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MilliporeSigma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us